Clinigen Group PLC | Income Statement
Fiscal year is July-June. All values GBP Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
122,580.00
126,639.00
184,400.00
339,900.00
302,300.00
381,200
Cost of Goods Sold (COGS) incl. D&A
89,203.00
88,726.00
138,100.00
264,600.00
198,800.00
266,300
Gross Income
33,377.00
37,913.00
46,300.00
75,300.00
103,500.00
114,900
SG&A Expense
12,868.00
14,597.00
21,500.00
50,500.00
60,900.00
64,400
EBIT
20,509.00
23,316.00
-
-
42,600.00
50,500
Unusual Expense
5,909.00
1,801.00
13,500.00
7,000.00
27,500.00
10,300
Non Operating Income/Expense
-
-
2,100.00
1,600.00
200.00
-
Interest Expense
95.00
234.00
900.00
3,900.00
2,000.00
5,400
Pretax Income
14,512.00
21,283.00
8,300.00
15,500.00
13,300.00
35,100
Income Tax
3,180.00
5,070.00
2,600.00
2,400.00
10,300.00
8,500
Equity in Affiliates
-
-
-
400.00
800.00
800
Consolidated Net Income
11,332.00
16,213.00
5,700.00
13,500.00
3,800.00
27,400
Net Income
11,332.00
16,213.00
5,700.00
13,500.00
3,800.00
27,400
Net Income After Extraordinaries
11,332.00
16,213.00
5,700.00
13,500.00
3,800.00
27,400
Net Income Available to Common
11,332.00
16,213.00
5,700.00
13,500.00
3,800.00
27,400
EPS (Basic)
0.15
0.20
0.07
0.12
0.03
0.23
Basic Shares Outstanding
74,814.80
82,555.60
87,200.00
113,100.00
115,000.00
119,900
EPS (Diluted)
0.14
0.19
0.06
0.12
0.03
0.22
Diluted Shares Outstanding
82,326.00
85,209.60
89,800.00
114,400.00
116,800.00
121,800
EBITDA
22,385.00
26,818.00
32,200.00
45,600.00
61,800.00
74,300
Non-Operating Interest Income
7.00
2.00
-
-
-
300
About Clinigen Group
View Profile
